Dr. Daphna Laifenfeld on the THERAPY+ Podcast: Rethinking Depression and Neuroplasticity
In this podcast episode, NeuroKaire Co-founder and CSO Dr. Daphna Laifenfeld discusses how antidepressants influence the brain, why neuroplasticity is key to recovery, and how NeuroKaire’s innovative approach could transform the future of depression treatment.
Join Dr. Daphna Laifenfeld, Co-founder and Chief Scientific Officer of NeuroKaire, as she delves into the evolving science behind major depressive disorder (MDD). In this podcast conversation, Daphna breaks down how antidepressants act on the brain and why their effects are closely tied to neuroplasticity—the brain’s remarkable ability to adapt and reorganize itself.
She also explores why traditional, trial-and-error approaches to treating depression often fall short, and how NeuroKaire’s platform is paving the way for more personalized, biology-driven care. Discover how new insights into neuroplasticity could reshape not just our understanding of depression, but the way we approach its treatment.
Whether you’re a clinician, researcher, or someone personally affected by depression, this episode offers valuable perspectives on the promise of precision psychiatry and the next frontier in mental health care.
Listen on Apple Podcasts here: https://podcasts.apple.com/us/podcast/therapy/id1776413144?i=1000717496154
Listen on Spotify here: https://open.spotify.com/episode/00ROU6K6EaVo6bWzJ1z6Hz?si=2PEAPeTsQbW2vWTAOA8daQ
Contact Us
78 John Miller Way,
Kearny, NJ 07032, USA
Yigal Alon Street 126
Tel Aviv-Yafo, Israel